Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients

被引：6
|
作者：
Gaston, R [1 ]
Alloway, RR
Gaber, AO
Rossi, SJ
Schroeder, TJ
Irish, WD
Canafax, DM
First, MR
机构：
[1] Univ Alabama, Tuscaloosa, AL 35487 USA
[2] Univ Cincinnati, Cincinnati, OH 45221 USA
[3] Univ Tennessee, Knoxville, TN 37996 USA
[4] SangStat Med Corp, Menlo Park, CA USA
来源：
TRANSPLANTATION PROCEEDINGS | 1999年 / 31卷 / 1-2期
关键词：
D O I：
10.1016/S0041-1345(98)01647-9
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：326 / 327
页数：2
相关论文
共 50 条
  • [41] A limited sampling strategy for the estimation of 12-hour SangCya and Neoral AUCs in renal transplant recipients
    Meier-Kriesche, HU
    Alloway, R
    Osama, A
    Canafax, DM
    Kaplan, B
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (02): : 166 - 171
  • [42] Safety and tolerability of CyA microemulsion formulation (Sandimmune Neoral) in stable renal transplant patients after 24 months of treatment
    Offermann, G
    Korn, A
    [J]. TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2204 - 2206
  • [43] Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients
    Van Buren, D
    Payne, J
    Geevarghese, S
    MacDonell, R
    Chapman, W
    Wright, JK
    Helderman, JH
    Richie, R
    Pinson, CW
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1830 - 1832
  • [44] Pharmacokinetic investigations of neoral absorption variability in renal transplant recipients.
    Klauser, R
    Irschik, H
    Kletzmayr, J
    Brunner, W
    Kovarik, J
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3209 - A3209
  • [45] Comparison of neoral and sandimmune preparations in renal transplant patients - Improved pharmacokinetics with neoral
    Warrens, AN
    Salama, A
    Waters, JB
    Lechler, RI
    [J]. TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2169 - 2170
  • [46] Results of conversion from sandimmune to neoral in stable pediatric liver transplant recipients after two years
    Dunn, SP
    Falkenstein, K
    Pierson, A
    Cooney, GF
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1962 - 1963
  • [47] Converting renal transplant patients maintained on Sandimmune to a new microemulsion formulation, Sandimmune Neoral
    Chu, SH
    Pang, ST
    Chiang, YJ
    Chuang, CK
    Chen, HW
    Chen, CS
    Chou, CC
    Huang, CC
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (07) : 3521 - 3523
  • [48] An open randomized parallel group study to compare Sandimmune Neoral with Sandimmune soft gelatin capsule in stable renal transplant patients
    Park, K
    Koh, YB
    Kwak, JY
    Kim, SJ
    Yoon, YS
    Kang, CM
    Kim, YS
    [J]. TRANSPLANTATION PROCEEDINGS, 1996, 28 (03) : 1202 - 1203
  • [49] ECONOMIC-ANALYSIS OF SANDIMMUNE-NEORAL IN CANADA IN STABLE RENAL-TRANSPLANT PATIENTS
    KEOWN, P
    LAWEN, JG
    LANDSBERG, D
    BEAUREGARDZOLLINGER, L
    RIVIERE, M
    LECLERC, C
    HARDENS, M
    [J]. TRANSPLANTATION PROCEEDINGS, 1995, 27 (02) : 1845 - 1848
  • [50] Reduced intrapatient variability of cyclosporine pharmacokinetics in renal transplant recipients switched from oral Sandimmune to Neoral
    Mendez, R
    Abboud, H
    Burdick, J
    Copley, B
    Freeman, R
    Batiuk, TD
    Cooney, GF
    Barbeito, R
    [J]. CLINICAL THERAPEUTICS, 1999, 21 (01) : 160 - 171
12345